Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387408852> ?p ?o ?g. }
- W4387408852 abstract "Loss of P-glycoprotein (P-gp) at the blood-brain barrier contributes to amyloid-β (Aβ) brain accumulation in Alzheimer's disease (AD). Using transgenic human amyloid precursor protein (hAPP)-overexpressing mice (Tg2576), we previously showed that Aβ triggers P-gp loss by activating the ubiquitin-proteasome pathway, which leads to P-gp degradation. Furthermore, we showed that inhibiting the ubiquitin-activating enzyme (E1) prevents P-gp loss and lowers Aβ accumulation in the brain of hAPP mice. Based on these data, we hypothesized that repurposing the FDA-approved proteasome inhibitor, bortezomib (Velcade®; BTZ), protects blood-brain barrier P-gp from degradation in hAPP mice in vivo.We treated hAPP mice with the proteasome inhibitor BTZ or a combination of BTZ with the P-gp inhibitor cyclosporin A (CSA) for 2 weeks. Vehicle-treated wild-type (WT) mice were used as a reference for normal P-gp protein expression and transport activity. In addition, we used the opioid receptor agonist loperamide as a P-gp substrate in tail flick assays to indirectly assess P-gp transport activity at the blood-brain barrier in vivo. We also determined P-gp protein expression by Western blotting, measured P-gp transport activity levels in isolated brain capillaries with live cell confocal imaging and assessed Aβ plasma and brain levels with ELISA.We found that 2-week BTZ treatment of hAPP mice restored P-gp protein expression and transport activity in brain capillaries to levels found in WT mice. We also observed that hAPP mice displayed significant loperamide-induced central antinociception compared to WT mice indicating impaired P-gp transport activity at the blood-brain barrier of hAPP mice in vivo. Furthermore, BTZ treatment prevented loperamide-induced antinociception suggesting BTZ protected P-gp loss in hAPP mice. Further, BTZ-treated hAPP mice had lower Aβ40 and Aβ42 brain levels compared to vehicle-treated hAPP mice.Our data indicate that BTZ protects P-gp from proteasomal degradation in hAPP mice, which helps to reduce Aβ brain levels. Our data suggest that the proteasome system could be exploited for a novel therapeutic strategy in AD, particularly since increasing Aβ transport across the blood-brain barrier may prove an effective treatment for patients." @default.
- W4387408852 created "2023-10-07" @default.
- W4387408852 creator A5013242084 @default.
- W4387408852 creator A5016812203 @default.
- W4387408852 creator A5037369499 @default.
- W4387408852 creator A5051148247 @default.
- W4387408852 creator A5093018528 @default.
- W4387408852 date "2023-10-06" @default.
- W4387408852 modified "2023-10-16" @default.
- W4387408852 title "Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model" @default.
- W4387408852 cites W1482389276 @default.
- W4387408852 cites W1538925586 @default.
- W4387408852 cites W1616122655 @default.
- W4387408852 cites W169071332 @default.
- W4387408852 cites W1744830941 @default.
- W4387408852 cites W1863440278 @default.
- W4387408852 cites W1863554483 @default.
- W4387408852 cites W1863776537 @default.
- W4387408852 cites W1929267935 @default.
- W4387408852 cites W1963640795 @default.
- W4387408852 cites W1968172974 @default.
- W4387408852 cites W1972076184 @default.
- W4387408852 cites W1974572321 @default.
- W4387408852 cites W1975106677 @default.
- W4387408852 cites W1983956828 @default.
- W4387408852 cites W1984941563 @default.
- W4387408852 cites W1986413832 @default.
- W4387408852 cites W1998832782 @default.
- W4387408852 cites W2001210466 @default.
- W4387408852 cites W2014426079 @default.
- W4387408852 cites W2021759214 @default.
- W4387408852 cites W2024865604 @default.
- W4387408852 cites W2025944561 @default.
- W4387408852 cites W2040809334 @default.
- W4387408852 cites W2042634665 @default.
- W4387408852 cites W2047766466 @default.
- W4387408852 cites W2051539817 @default.
- W4387408852 cites W2051585841 @default.
- W4387408852 cites W2053001944 @default.
- W4387408852 cites W2059631065 @default.
- W4387408852 cites W2078068647 @default.
- W4387408852 cites W2082429191 @default.
- W4387408852 cites W2090453777 @default.
- W4387408852 cites W2093366614 @default.
- W4387408852 cites W2095568016 @default.
- W4387408852 cites W2096410114 @default.
- W4387408852 cites W2100258988 @default.
- W4387408852 cites W2102236934 @default.
- W4387408852 cites W2114533524 @default.
- W4387408852 cites W2130945756 @default.
- W4387408852 cites W2136365100 @default.
- W4387408852 cites W2140975778 @default.
- W4387408852 cites W2153507776 @default.
- W4387408852 cites W2163209521 @default.
- W4387408852 cites W2165503155 @default.
- W4387408852 cites W2167527439 @default.
- W4387408852 cites W2168538246 @default.
- W4387408852 cites W2236313888 @default.
- W4387408852 cites W2271636521 @default.
- W4387408852 cites W2300070246 @default.
- W4387408852 cites W2331586707 @default.
- W4387408852 cites W2486764459 @default.
- W4387408852 cites W2544147855 @default.
- W4387408852 cites W2588265708 @default.
- W4387408852 cites W2766826981 @default.
- W4387408852 cites W2803122042 @default.
- W4387408852 cites W2810140467 @default.
- W4387408852 cites W2811294256 @default.
- W4387408852 cites W2890392586 @default.
- W4387408852 cites W2977606681 @default.
- W4387408852 cites W3012153896 @default.
- W4387408852 cites W3081259848 @default.
- W4387408852 cites W3083659245 @default.
- W4387408852 cites W3092214519 @default.
- W4387408852 cites W3116357516 @default.
- W4387408852 cites W3134918769 @default.
- W4387408852 cites W3135018637 @default.
- W4387408852 cites W3135157172 @default.
- W4387408852 cites W4210271919 @default.
- W4387408852 doi "https://doi.org/10.1186/s12987-023-00470-z" @default.
- W4387408852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37803468" @default.
- W4387408852 hasPublicationYear "2023" @default.
- W4387408852 type Work @default.
- W4387408852 citedByCount "0" @default.
- W4387408852 crossrefType "journal-article" @default.
- W4387408852 hasAuthorship W4387408852A5013242084 @default.
- W4387408852 hasAuthorship W4387408852A5016812203 @default.
- W4387408852 hasAuthorship W4387408852A5037369499 @default.
- W4387408852 hasAuthorship W4387408852A5051148247 @default.
- W4387408852 hasAuthorship W4387408852A5093018528 @default.
- W4387408852 hasBestOaLocation W43874088521 @default.
- W4387408852 hasConcept C102230213 @default.
- W4387408852 hasConcept C104317684 @default.
- W4387408852 hasConcept C126322002 @default.
- W4387408852 hasConcept C133936738 @default.
- W4387408852 hasConcept C134018914 @default.
- W4387408852 hasConcept C141035611 @default.
- W4387408852 hasConcept C150903083 @default.
- W4387408852 hasConcept C185592680 @default.
- W4387408852 hasConcept C207001950 @default.